RJF — Laboratorio Reig Jofre, S.A.

RJFLaboratorio Reig Jofre, S.A.

BME · ES · Healthcare · Drug Manufacturers - Specialty & Generic · reigjofre.com

2.710EUR+0.74%Mkt Cap: 220.63M EURP/E: 54.20Last update: 2026-05-14

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical…

Industry Peers

Drug Manufacturers - Specialty & Generic

SOBI

Swedish Orphan Biovitrum AB (publ)

153.14BSEKP/E 167.7

ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

Turk Ilac Ve Serum Sanayi Anonim Sirketi

3.09BTRY—

ROVI

Laboratorios Farmaceuticos Rovi, S.A.

3.02BEURP/E 25.0

loading…

Indicators:|

Key Statistics

Valuation

P/E (Trailing)54.20

P/E (Forward)22.58

PEG0.37

P/B1.01

P/S0.66

EV/EBITDA13.40

EV/Revenue0.91

EPS (TTM)0.05

EPS (Forward)0.12

Cash Flow & Leverage

FCF Yield—

FCF Margin—

Operating CF1.51M EUR

CapEx (TTM)18.30M EUR

Net Debt/EBITDA3.59

Net Debt81.69M EUR

Technical

SMA 502.585 (+4.9%)

SMA 2002.746 (-1.3%)

Beta0.95

S&P 52W Chg24.23%

Avg Vol (30d)16.21K

Avg Vol (10d)14.52K

Technical Indicators

RSI (14)53.0

MACD0.0382

MACD Signal0.0512

MACD Hist.-0.0129

BB Upper2.813 EUR

BB Middle2.732 EUR

BB Lower2.652 EUR

BB Width5.91%

ATR (14)0.0612 EUR

Vol Ratio (20d)0.05x

52W Range

2.32036% of range3.400

52W High3.400 EUR

52W Low2.320 EUR

Profitability

Gross Margin59.15%

EBITDA Margin6.79%

Profit Margin1.52%

Oper. Margin4.03%

ROE2.30%

ROA1.27%

Revenue Growth-1.90%

Earnings Growth—

Balance Sheet

Debt/Equity0.42

Current Ratio1.55

Quick Ratio0.87

Book Value/Sh2.679 EUR

Cash/Share0.2650 EUR

Dividends

Fwd Div Rate0.0500 EUR

Trail. Div Rate0.0000 EUR

Div. Yield1.81%

5Y Avg Yield1.51%

Payout Ratio94.59%

Ex-Div DateMay 15, 2025

Pay Date—

Splits

Last Split1:20

Split DateSep 22, 2015

Ownership

Shares Out.81.41M

Float21.47M

Insiders79.09%

Institutions7.33%

Analyst Consensus

Rating0.0 (Hold)

Target (Mean)—

Target Range—

# Analysts—

Company

Market Cap220.63M EUR

Enterprise Value304.61M EUR

Revenue (TTM)335.01M EUR

Gross Profit195.85M EUR

Net Income (TTM)5.02M EUR

Revenue/Share4.115 EUR

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees1.4K

Last Price2.710 EUR

CountryES

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINES0165359029